Advertisement

Reactions Weekly

, Volume 1776, Issue 1, pp 27–27 | Cite as

Alemtuzumab

Fulminant viral hepatitis: case report
Case report
  • 20 Downloads

Reference

  1. Falt A, et al. A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3). Multiple Sclerosis Journal 24 (Suppl.): 706-707, No. 2, Oct 2018. Available from: URL: http://doi.org/10.1177/1352458518798591 [abstract] - Sweden

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations